APITBIO
Songpa-gu, South Korea · apitbio.com
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
APITBIO is an antibody-based biotech company developing precision medicines and innovative new drugs. It works on antibody discovery, engineering, optimization, production, and bispecific antibody platforms, and it also collaborates on ADC and CAR-T development.
Their website has a general contact form; we send your quote request through it.
What they offer
Antibody Library
Uses a proprietary synthetic fully human antibody library with more than 20 billion diversity to discover monoclonal antibodies.
Antibody Discovery
Selects and discovers antibodies with high specificity using a synthetic antibody library with low immunogenicity and high diversity.
Antibody Engineering
Converts screened Fab fragments into full IgG format using one-vector or two-vector systems and optimizes IgG expression.
Antibody Optimization
Improves antibodies through affinity maturation and other optimization steps to develop therapeutics with better efficacy and productivity.
Antibody Production, Purification, and Analysis
Produces, purifies, and analyzes antibodies for preclinical rodent and non-human primate toxicity studies and lab-scale process research.
Bispecific Antibody Platform
Creates bispecific antibodies that bind two antigens, including symmetric and asymmetric formats, with Fc engineering for ADCC control.
What they work on
- Modalities
- Antibody, Bispecific, ADC, Cell therapy
- Species and models
- Non-human primate
- Assays and studies
- antibody screening, antibody discovery, antibody engineering, affinity maturation, production, purification, analysis
Similar labs. Biocytogen, BPS Bioscience, Intellective Bio, Kyinno Bio
Found in a contract services directory. Listing built from apitbio.com. Work here? Claim this listing.